Startups and precision medicine
A good take on a few startups in the field of omics in Forbes
Probiotics on steroids!
The new world of probiotics beautifully described in this Forbes article
How not to deliver bad news…
Should patients receive the results of a positive BRCA mutation in the mail ? A 23andme customer describes her experience. Read the article
On the complexity of oncology drug development
This article explains why so many compounds that cure cancer in lab mice fail in clinical trials, where some 95% flame out . The genes we thought were responsible for making the surviving of cancer essentials turn out to be insignificant.
Do not fear the silver economy
An article of the MIT Technology Review on the effect an aging population has on the economy.
HRT and breast cancer… the unfinished story
StatNews report on The Lancet study that reviewed data on more than 100,000 women who’d developed breast cancer after menopause. The study shows that 6,3% of women who never used HRT developed breast cancer versus 8,3% in women who used the combination of hormonal therapy…
10,000 steps is more like 7,500…
So much for the Japanese marketing campaign advocating the 10,000 step-a-day…, Read the article
« ASCO, The Woodstock of oncologists »
Some stats from STATnews The compounded annual growth rate in spending on oncology drugs is forecast to rise between 11% and 14%, bringing the total market to $200 billion to $230 billion. If you include supportive care, which is forecast to fall by as much…
A new blood test to detect cancer ?
The race is on for the development of a test to detect cancer. Read the article
Google to sell its AR glasses for $999.00
The company will continue to sell the glasses in a B2B model Read the article
Stay connected